
|Articles|December 10, 2015
Podcast: FDA’s New Mobile Apps: Q&A with Paul Buckman
Advertisement
Paul Buckman (Director, Division of Online Communications, CDER, FDA) explains the impetus for FDA’s mobile apps and announces FDA’s newest mobile app,
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




